ClinicalTrials.gg
Not yet recruitingNCT07499843Updated Mar 30, 2026

Synchronous vs. Asynchronous Telerehabilitation for High-Risk Infants

An interventional study of Synchronous Telerehabilitation Group and Asynchronous Telerehabilitation Group in Risky Baby, Premature Birth of Newborn and Motor Delay, sponsored by Biruni University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 6 Months to 9 Months. Per ClinicalTrials.gov, last updated 2026-03-30.

Sponsored by Biruni University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
6 Months to 9 Months
Sex
All
01

Study summary

Premature birth, low birth weight, and a history of neonatal intensive care history are significant risk factors associated with long-term neurodevelopmental adverse outcomes in infants. Family-centered early intervention programs play a critical role in minimizing the impact of these risks and optimizing developmental potential. Currently, telerehabilitation (TR) has emerged as a cost-effective solution that facilitates access to early intervention services. However, there is limited literature directly comparing the efficacy and feasibility of synchronous (real-time) and asynchronous (store-and-forward) parent coaching-based TR models specifically within the at-risk infant population.

The primary objective of this project is to comparatively examine the effects of synchronous and asynchronous TR programs on motor development levels, individualized goal attainment, and parental self-efficacy in infants aged 6-9 months (corrected age) at risk of developmental delay, against a standard home program (control group). Designed as a randomized controlled trial, the study will include 45 high-risk infants meeting the inclusion criteria, who will be randomly allocated into three groups: Synchronous TR, Asynchronous TR, and Control. In the Synchronous group, parents will receive real-time coaching via video conferencing for 12 weeks, whereas the Asynchronous group process will be managed through video analysis and delayed feedback mechanisms. The Control group will be provided with standard digital educational materials.

The primary outcome measures of the study include Goal Attainment Scaling (GAS) scores, the Parental Self-Efficacy Instrument, and the Parenting Stress Index. Secondary measures will include the Bayley Scales of Infant and Toddler Development (Bayley-IV), the Alberta Infant Motor Scale (AIMS), and the Hammersmith Infant Neurological Examination (HINE). Data will be collected at baseline (T0) and post-intervention (T1) by an assessor blinded to group allocation. The findings obtained from this study aim to demonstrate the clinical efficacy of different TR models, thereby providing guidance for the planning and dissemination of remote healthcare services for high-risk infants.

02

Conditions studied

  • Risky Baby
  • Premature Birth of Newborn
  • Motor Delay

Keywords

  • At-risk infant
  • Early intervention
  • Telerehabilitation
  • Parent coaching
  • Motor development
03

In context

Premature Birth

2,550 studies on the registry are indexed under Premature Birth; 500 are open to participants now.

This study's planned enrollment of 48 is below the median of 84 across 1,666 interventional studies indexed under Premature Birth.

Browse Premature Birth studies →

Lead sponsor

Biruni University is the lead sponsor of 180 studies on the registry; 45 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Months to 9 Months
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Gestational age ≤32 weeks and/or birth weight ≤1500 grams.
  • Corrected age between 6 and 9 months at the time of enrollment.
  • Referral to a pediatric neurology clinic and/or current follow-up by a pediatric neurologist due to developmental risk.
  • A total score of ≤73 on the Hammersmith Infant Neurological Examination (HINE) (Romeo et al., 2021; Novak et al., 2017).
  • A score ≤5th percentile on the Alberta Infant Motor Scale (AIMS) (Fuentefria et al., 2017).
  • Parental willingness to participate and signing of the " Form."
  • Access to the minimum technological infrastructure required for telerehabilitation (smartphone, tablet, or computer with video calling capability and active internet access).

Exclusion criteria

Exclusion Criteria:

  • Presence of diagnosed genetic syndromes or metabolic diseases known to directly affect neuro-motor development.
  • Major congenital malformations causing significant movement restriction or exercise intolerance.
  • History of symptomatic hypoglycemia associated with severe brain injury during the neonatal period.
  • Sensory impairments (bilateral blindness or severe bilateral hearing loss not correctable with hearing aids) that prevent participation in assessments and exercises based on visual and auditory stimuli.
  • Acute or unstable clinical conditions that preclude the safe conduct of the intervention (e.g., continuous mechanical ventilation, hemodynamic instability, uncontrolled seizures, or active acute infections).
  • Non-adherence to the study protocol, defined as missing more than 6 intervention sessions.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
48 participants (estimated)

Study arms

  • Other
    Synchronous Telerehabilitation Group

    Participants in the synchronous group will receive a 12-week telerehabilitation program based on a 'parent coaching' model. The intervention consists of weekly 45-minute real-time video consultations via Zoom. To optimize session efficiency, parents receive standardized pre-session guidance (camera setup, infant readiness) via WhatsApp. The physiotherapist acts as a remote coach, providing live verbal and visual feedback to guide parents as the primary implementers during natural daily routines (play, feeding, care). Each session involves evaluating Goal Attainment Scaling (GAS) objectives from the previous week and collaborative development of new motor strategies and environmental modifications tailored to the infant's current developmental needs.

    Other: Synchronous Telerehabilitation Group

  • Other
    Asynchronous Telerehabilitation Group

    Participants in the asynchronous group will follow a 12-week telerehabilitation program based on a parent coaching model with a delayed feedback principle. To ensure therapeutic intensity equivalent to the synchronous sessions, parents will record and submit 10-15 minutes of video clips weekly, showing intervention activities integrated into daily routines (play, feeding, care). These videos are shared via secure, end-to-end encrypted messaging. The physiotherapist performs a detailed analysis of the parents' handling techniques and the infant's movement quality. Feedback is provided through recorded demonstration videos (using a model doll or the therapist) to correct or reinforce motor patterns. Each weekly cycle includes evaluating Goal Attainment Scaling (GAS) objectives and updating motor strategies based on the infant's current developmental needs.

    Other: Asynchronous Telerehabilitation Group

  • No intervention
    Control Group

    Participants in the control group will follow a standard home-based program without active physiotherapist supervision or individualized coaching. At baseline (T0), infant-specific Goal Attainment Scaling (GAS) parameters are established. Families receive comprehensive standardized educational materials, including a 'Parent Education Booklet' (PDF) and instructional videos demonstrating motor activities and positioning. Throughout the 12-week period, families implement these strategies independently. Unlike the experimental groups, no live feedback, video analysis, or weekly goal revisions are provided; GAS goals remain fixed and are evaluated only at the 12th week (T1). For ethical monitoring, brief phone calls are conducted at weeks 4 and 8 to assess study adherence and general health, strictly excluding any therapeutic guidance or intervention updates.

Interventions

  • OtherSynchronous Telerehabilitation Group

    A 12-week remote physiotherapy program based on a 'parent coaching' model delivered via real-time video conferencing (Zoom). The intervention consists of weekly 45-minute sessions where the physiotherapist acts as a coach, providing live verbal and visual guidance to parents as the primary implementers of the intervention. Activities are integrated into the infant's natural daily routines (play, feeding, care). Pre-session standardized guidance (camera positioning, infant readiness) is provided via WhatsApp. Clinical progress is monitored through weekly evaluation and updating of Goal Attainment Scaling (GAS) objectives tailored to the infant's developmental needs.

  • OtherAsynchronous Telerehabilitation Group

    A 12-week remote physiotherapy program based on a parent coaching model using a delayed feedback principle. To ensure therapeutic intensity equivalent to synchronous sessions, parents record and submit 10-15 minutes of video clips weekly through secure, end-to-end encrypted messaging. These clips demonstrate intervention activities integrated into daily routines (play, feeding, care). The physiotherapist performs a detailed analysis of handling techniques and movement quality, providing feedback via recorded demonstration videos (using a model doll or the therapist) to correct or reinforce motor patterns. Each weekly cycle includes evaluating Goal Attainment Scaling (GAS) objectives and updating motor strategies based on the infant's current developmental needs.

06

What researchers measure

Primary outcomes

  1. Goal Attainment Scaling

    Goal Attainment Scaling (GAS) is a standardized method used to evaluate the achievement of individualized treatment goals in pediatric rehabilitation. For each infant, 3 to 5 SMART (specific, measurable, attainable, relevant, and time-bound) goals are collaboratively established by the physiotherapist and the family. Each goal is scored on a 5-point scale: -2 (baseline level), -1 (less than expected), 0 (expected outcome), +1 (more than expected), and +2 (much more than expected). The raw scores are converted into a standardized T-score using the formula with a mean of 50 and a standard deviation of 10. A T-score of 50 or higher indicates that the intervention has successfully met or exceeded the expected goals.

    Time frame: Baseline and after 12 weeks

  2. Parental Self-Efficacy Instrument for Children with Disabilities

    The Parental Self-Efficacy Scale, developed by Guimond et al. (2005) and adapted into Turkish by Cavkaytar et al. (2014), assesses the self-efficacy perceptions of parents of children with disabilities regarding their caregiving and child-rearing capacities. The scale consists of 17 items rated on a 5-point Likert-type scale. It is primarily administered as a self-report tool, with researchers providing assistance (reading items) for illiterate participants if necessary. The Turkish version demonstrated high internal consistency (Cronbach's Alpha = 0.95) and test-retest reliability (r = 0.79). Total scores range from 17 to 85, where higher scores indicate a greater sense of parenting competence and self-efficacy in their roles.

    Time frame: Baseline and after 12 weeks

  3. Parenting Stress Index - Short Form (PSI-SF)

    The Parenting Stress Index - Short Form (PSI-SF), originally developed by Abidin (1983) and validated in Turkish by Mert et al. (2008), is a 36-item self-report instrument designed to assess stress within the parent-child system. It consists of three subscales (12 items each): Parental Distress, Parent-Child Dysfunctional Interaction, and Difficult Child. The Total Stress score is calculated by summing these three subscale scores. Total scores range from 36 to 180, where higher scores represent higher levels of perceived parenting stress. The Turkish version demonstrated internal consistency (Cronbach's Alpha = 0.71 for Total Stress; 0.76-0.81 for subscales) and high test-retest reliability (r = 0.88).

    Time frame: Baseline and after 12 weeks

Secondary outcomes

  1. Hammersmith Infant Neurological Examination

    The Hammersmith Infant Neurological Examination (HINE) is a standardized, quantitative tool for the neurological assessment of infants aged 2 to 24 months. It comprises three sections: (1) a 26-item neurological examination assessing cranial nerve function, posture, movement quality, muscle tone, and reflexes; (2) an 8-item assessment of developmental motor milestones; and (3) a 3-item behavioral assessment. The total neurological score is derived from the 26 items in the first section, with a maximum possible score of 78. Higher scores indicate better neurological development and maturity.

    Time frame: Baseline and after 12 weeks

  2. Bayley Scales of Infant and Toddler Development, Fourth Edition

    The Bayley Scales of Infant and Toddler Development, Fourth Edition (Bayley-IV) is a comprehensive assessment used to evaluate developmental functioning in infants and toddlers aged 16 days to 42 months. It covers five primary domains: Cognitive, Language (Receptive and Expressive), Motor (Fine and Gross), Social-Emotional, and Adaptive Behavior. The assessment involves interactive tasks with the child and caregiver questionnaires. Standardized composite scores are calculated for each domain, with scores below the 10th percentile indicating a risk of developmental delay. For this study, all assessments will be conducted by certified researchers to ensure standardized administration and scoring.

    Time frame: Baseline and after 12 weeks

  3. Alberta Infant Motor Scale

    The Alberta Infant Motor Scale (AIMS), developed by Piper and Darrah (1992), is a norm-referenced standardized instrument used to assess the gross motor development of infants from birth through independent walking (approx. 18 months). It consists of 58 items distributed across four postural positions: prone (21), supine (9), sitting (12), and standing (16). Scoring is based on clinical observation of weight-bearing, postural alignment, and anti-gravity movements. The total score ranges from 0 to 58, where higher scores indicate more advanced gross motor maturation (Piper \& Darrah, 1992; Eliks et al., 2022).

    Time frame: Baseline and after 12 weeks

  4. Telehealth Usability Questionnaire

    The Telehealth Usability Questionnaire (TUQ), developed by Parmanto et al. (2016) and validated in Turkish (Ozden et al., 2021), is a 21-item instrument designed to evaluate the quality of telerehabilitation services, software, and systems. It assesses six domains: usefulness, ease of use and learnability, interface quality, interaction quality, reliability, and satisfaction. Items are rated on a 7-point Likert scale (1=Strongly Disagree, 7=Strongly Agree). Total scores range from 21 to 147, where higher scores indicate greater usability and satisfaction with the telehealth system. This scale will be used to compare the technical infrastructure performance and family-system interaction levels for both synchronous and asynchronous models.

    Time frame: Baseline and after 12 weeks

  5. Telemedicine Satisfaction Questionnaire

    The Telehealth Satisfaction Questionnaire (TSQ), developed by Yip et al. (2003) and validated in Turkish (Ozden et al., 2021), is a 14-item instrument designed to assess the level of satisfaction among participants receiving telehealth services. The questionnaire uses a 5-point Likert-type scale ranging from 1 (Strongly Disagree) to 5 (Strongly Agree). Total scores range from 14 to 70, where higher scores indicate a higher level of satisfaction with the telerehabilitation service provided.

    Time frame: Baseline and after 12 weeks

07

Study locations

1 site
  • Biruni University Department of Physiotherapy and Rehabilitation
    Istanbul, Zeyti̇nburnu 34010, Turkey (Türkiye)
    • GÜLSENA UTKU UMUT, PhD · Contactgulsenautkuumut@gmail.com · +905370664646
    • GÜLSENA UTKU UMUT, PhD · Principal investigator
    • MURAT ERMİŞ, MSC · Sub investigator
    • MEHMEHT AKİF KILIÇ, MD · Sub investigator
    • EDİBE PEMPEGÜL YILDIZ, PROF · Sub investigator
    • ZEYNEP HOŞBAY, PROF · Sub investigator
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared to protect the privacy of the infants and their families, as the study involves sensitive developmental data and video recordings. Ethical approval from the Institutional Review Board does not include permission for public data sharing.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for May 2026; primary completion for May 2027, 12 months later.

Of 741 non-industry interventional studies with no phase under Premature Birth, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 47. This study's planned 12 months is below that.

Counting every sponsor, half of 759 studies reached it within 24 months; a quarter within 12 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 18, 2026
First posted
Mar 30, 2026
StartEst.
May 4, 2026
Primary completionEst.
May 4, 2027
CompletionEst.
Jul 4, 2027
Last update
Mar 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07499843
Lead sponsor
Biruni University
Responsible party
Gülsena Utku Umut (Asst. Prof., Biruni University) — Principal investigator
First posted
Mar 30, 2026
Start date
May 4, 2026 (estimated)
Primary completion
May 4, 2027 (estimated)
Completion
Jul 4, 2027 (estimated)
Last update
Mar 30, 2026

Study contacts

GÜLSENA UTKU UMUT, PhD
Contact
gulsenautkuumut@gmail.com
+905370664646

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion